New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis
Aim of the work: This is the first experimental study to assess the possible synergistic effects of simvastatin combination with residronate, strontium ranelate and raloxifene on glucocorticoid induced osteoporosis (GIO) in female albino rats. Materials and methods: 48 mature healthy female albino r...
Main Authors: | Amira K. Khalifa, Sohier A. Diab, Ghada M. Hashem, Essam F. Alalkamy, Mira F. Yacoub |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Egyptian Rheumatologist |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116419300912 |
Similar Items
-
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01) -
Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
by: N V Toroptsova, et al.
Published: (2010-02-01) -
EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS
by: J M Kaufman, et al.
Published: (2012-08-01)